Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.
The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:
If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.
Chair
Maria Arcila, MD
Memorial Sloan Kettering Cancer Center (MSKCC)
Board Member (2022-2023)
Alexis Carter, MD
Children’s Hospital of Atlanta
Member (2022-2023)
Michael Hadjisavas, PhD
Member (2022-2023)
Robert L. Nussbaum, MD
Invitae
Member (2022-2023)
Jill Hagenkord, MD
Optum Genomics
Member (2022-2023)
Jordan Laser, MD
Everlywell
Member (2022-2023)
Anthony N. Sireci, MD, MS
Loxo-Lilly
President
Laura J. Tafe, MD
Dartmouth Hitchcock Medical Center
Executive Director (Non-Voting)
Mary Steele Williams, MNA, MT(ASCP)SM